ALT 0 3 0 3 B-clinical_variable
≤2.5 4 8 4 8 O
× 9 10 9 10 I-upper_bound
ULN 11 14 11 14 I-upper_bound

Active 0 6 15 21 O
or 7 9 22 24 O
history 10 17 25 32 O
of 18 20 33 35 O
any 21 24 36 39 O
autoimmune 25 35 40 50 B-chronic_disease
disease 36 43 51 58 I-chronic_disease

Adequate 0 8 59 67 O
hematological 9 22 68 81 O
function 23 31 82 90 O
defined 32 39 91 98 O
by 40 42 99 101 O
white 43 48 102 107 B-clinical_variable
blood 49 54 108 113 I-clinical_variable
cell 55 59 114 118 I-clinical_variable
( 60 61 119 120 I-clinical_variable
WBC 61 64 120 123 I-clinical_variable
) 64 65 123 124 I-clinical_variable
count 66 71 125 130 I-clinical_variable
≥3 72 74 131 133 O
× 75 76 134 135 I-lower_bound
10 77 79 136 138 I-lower_bound
^ 79 80 138 139 I-lower_bound
9 80 81 139 140 I-lower_bound
/ 81 82 140 141 I-lower_bound
L 82 83 141 142 I-lower_bound

Adequate 0 8 143 151 O
renal 9 14 152 157 O
function 15 23 158 166 O
, 23 24 166 167 O
defined 25 32 168 175 O
as 33 35 176 178 O
estimated 36 45 179 188 O
creatinine 46 56 189 199 B-clinical_variable
clearance 57 66 200 209 I-clinical_variable
> 67 68 210 211 O
30 68 70 211 213 B-lower_bound
mL 71 73 214 216 I-lower_bound
/ 73 74 216 217 I-lower_bound
min 74 77 217 220 I-lower_bound
according 78 87 221 230 O
to 88 90 231 233 O
Cockcroft 91 100 234 243 O
- 100 101 243 244 O
Gault 101 106 244 249 O
formula 107 114 250 257 O
or 115 117 258 260 O
measured 118 126 261 269 O
24 127 129 270 272 O
- 129 130 272 273 O
hour 130 134 273 277 O
creatinine 135 145 278 288 O
clearance 146 155 289 298 O
( 156 157 299 300 O
or 157 159 300 302 O
local 160 165 303 308 O
institutional 166 179 309 322 O
standard 180 188 323 331 O
method 189 195 332 338 O
) 195 196 338 339 O

Adequate 0 8 340 348 O
renal 9 14 349 354 O
function 15 23 355 363 O
, 23 24 363 364 O
defined 25 32 365 372 O
as 33 35 373 375 O
estimated 36 45 376 385 B-clinical_variable
creatinine 46 56 386 396 I-clinical_variable
clearance 57 66 397 406 I-clinical_variable
> 67 68 407 408 O
50 68 70 408 410 B-lower_bound
mL 71 73 411 413 I-lower_bound
/ 73 74 413 414 I-lower_bound
min 74 77 414 417 I-lower_bound
according 78 87 418 427 O
to 88 90 428 430 O
Cockcroft 91 100 431 440 O
- 100 101 440 441 O
Gault 101 106 441 446 O
formula 107 114 447 454 O
or 115 117 455 457 O
measured 118 126 458 466 O
24 127 129 467 469 O
- 129 130 469 470 O
hour 130 134 470 474 O
creatinine 135 145 475 485 O
clearance 146 155 486 495 O
( 156 157 496 497 O
or 157 159 497 499 O
local 160 165 500 505 O
institutional 166 179 506 519 O
standard 180 188 520 528 O
method 189 195 529 535 O
) 195 196 535 536 O

Any 0 3 537 540 O
psychiatric 4 15 541 552 B-chronic_disease
condition 16 25 553 562 I-chronic_disease
that 26 30 563 567 O
would 31 36 568 573 O
prohibit 37 45 574 582 O
understanding 46 59 583 596 O
or 60 62 597 599 O
rendering 63 72 600 609 O
of 73 75 610 612 O
informed 76 84 613 621 O
consent 85 92 622 629 O

Availability 0 12 630 642 O
of 13 15 643 645 O
a 16 17 646 647 O
formalin 18 26 648 656 O
- 26 27 656 657 O
fixed 27 32 657 662 O
paraffin 33 41 663 671 O
- 41 42 671 672 O
embedded 42 50 672 680 O
block 51 56 681 686 O
containing 57 67 687 697 O
tumor 68 73 698 703 B-cancer
tissue 74 80 704 710 O
or 81 83 711 713 O
7 84 85 714 715 O
unstained 86 95 716 725 O
tumor 96 101 726 731 O
slides 102 108 732 738 O
suitable 109 117 739 747 O
for 118 121 748 751 O
PD 122 124 752 754 O
- 124 125 754 755 O
L1 125 127 755 757 O
expression 128 138 758 768 O
assessment 139 149 769 779 O

Availability 0 12 780 792 O
of 13 15 793 795 O
tissue 16 22 796 802 O
for 23 26 803 806 O
HPV 27 30 807 810 B-chronic_disease
testing 31 38 811 818 O
( 39 40 819 820 O
paraffin 40 48 820 828 O
block 49 54 829 834 O
or 55 57 835 837 O
one 58 61 838 841 O
7-µm 62 66 842 846 O
section 67 74 847 854 O
on 75 77 855 857 O
a 78 79 858 859 O
slide 80 85 860 865 O
) 85 86 865 866 O

Availability 0 12 867 879 O
of 13 15 880 882 O
tumor 16 21 883 888 B-cancer
archival 22 30 889 897 O
material 31 39 898 906 O
or 40 42 907 909 O
fresh 43 48 910 915 O
biopsies 49 57 916 924 O
is 58 60 925 927 O
optional 61 69 928 936 O
for 70 73 937 940 O
subjects 74 82 941 949 O
in 83 85 950 952 O
dose 86 90 953 957 O
escalation 91 101 958 968 O

Chemotherapy 0 12 969 981 B-treatment
administered 13 25 982 994 O
concurrently 26 38 995 1007 O
with 39 43 1008 1012 O
primary 44 51 1013 1020 O
radiation 52 61 1021 1030 B-treatment
( 62 63 1031 1032 O
e.g. 63 67 1032 1036 O
, 67 68 1036 1037 O
weekly 69 75 1038 1044 O
cisplatin 76 85 1045 1054 B-treatment
) 85 86 1054 1055 O

Clinically 0 10 1056 1066 O
significant 11 22 1067 1078 O
( 23 24 1079 1080 O
i.e. 24 28 1080 1084 O
, 28 29 1084 1085 O
active 30 36 1086 1092 O
) 36 37 1092 1093 O
cardiovascular 38 52 1094 1108 B-chronic_disease
disease 53 60 1109 1116 I-chronic_disease

Effective 0 9 1117 1126 O
contraception 10 23 1127 1140 O
must 24 28 1141 1145 O
be 29 31 1146 1148 O
used 32 36 1149 1153 O
30 37 39 1154 1156 O
days 40 44 1157 1161 O
before 45 51 1162 1168 O
first 52 57 1169 1174 O
study 58 63 1175 1180 O
drug 64 68 1181 1185 O
administration 69 83 1186 1200 O
, 83 84 1200 1201 O
for 85 88 1202 1205 O
the 89 92 1206 1209 O
duration 93 101 1210 1218 O
of 102 104 1219 1221 O
trial 105 110 1222 1227 O
participation 111 124 1228 1241 O
, 124 125 1241 1242 O
and 126 129 1243 1246 O
≥60 130 133 1247 1250 O
days 134 138 1251 1255 I-lower_bound
after 139 144 1256 1261 O
stopping 145 153 1262 1270 O
trial 154 159 1271 1276 O
participation 160 173 1277 1290 O

Effects 0 7 1291 1298 O
of 8 10 1299 1301 O
the 11 14 1302 1305 O
study 15 20 1306 1311 O
drug 21 25 1312 1316 O
on 26 28 1317 1319 O
the 29 32 1320 1323 O
developing 33 43 1324 1334 O
human 44 49 1335 1340 O
fetus 50 55 1341 1346 O
are 56 59 1347 1350 O
unknown 60 67 1351 1358 O
. 67 68 1358 1359 O
Thus 69 73 1360 1364 O
, 73 74 1364 1365 O
women 75 80 1366 1371 B-gender
of 81 83 1372 1374 O
childbearing 84 96 1375 1387 O
potential 97 106 1388 1397 O
and 107 110 1398 1401 O
men 111 114 1402 1405 O
must 115 119 1406 1410 O
agree 120 125 1411 1416 B-contraception_consent
to 126 128 1417 1419 I-contraception_consent
use 129 132 1420 1423 I-contraception_consent
effective 133 142 1424 1433 I-contraception_consent
contraception 143 156 1434 1447 I-contraception_consent
, 156 157 1447 1448 O
defined 158 165 1449 1456 O
as 166 168 1457 1459 O
2 169 170 1460 1461 O
barrier 171 178 1462 1469 O
methods 179 186 1470 1477 O
, 186 187 1477 1478 O
or 188 190 1479 1481 O
1 191 192 1482 1483 O
barrier 193 200 1484 1491 O
method 201 207 1492 1498 O
with 208 212 1499 1503 O
a 213 214 1504 1505 O
spermicide 215 225 1506 1516 B-contraception_consent
, 225 226 1516 1517 O
an 227 229 1518 1520 O
intrauterine 230 242 1521 1533 O
device 243 249 1534 1540 O
or 250 252 1541 1543 O
use 253 256 1544 1547 O
of 257 259 1548 1550 O
oral 260 264 1551 1555 O
female 265 271 1556 1562 O
contraceptive 272 285 1563 1576 O

Efficacy 0 8 1577 1585 B-cancer
Expansion 9 18 1586 1595 I-cancer
Cohort 19 25 1596 1602 I-cancer
( 26 27 1603 1604 I-cancer
Second 27 33 1604 1610 I-cancer
- 33 34 1610 1611 I-cancer
Line 34 38 1611 1615 I-cancer
Cervical 39 47 1616 1624 I-cancer
Cancer 48 54 1625 1631 I-cancer
) 54 55 1631 1632 I-cancer

For 0 3 1633 1636 O
subjects 4 12 1637 1645 O
with 13 17 1646 1650 O
metastatic 18 28 1651 1661 B-cancer
melanoma 29 37 1662 1670 I-cancer
, 37 38 1670 1671 O
prior 39 44 1672 1677 B-treatment
treatment 45 54 1678 1687 I-treatment
with 55 59 1688 1692 O
CTLA-4 60 66 1693 1699 B-treatment
- 66 67 1699 1700 I-treatment
blocking 67 75 1700 1708 I-treatment
antibody 76 84 1709 1717 I-treatment
is 85 87 1718 1720 O
permissible 88 99 1721 1732 O

Histologic 0 10 1733 1743 O
confirmation 11 23 1744 1756 O
of 24 26 1757 1759 O
the 27 30 1760 1763 O
original 31 39 1764 1772 O
primary 40 47 1773 1780 B-cancer
tumor 48 53 1781 1786 I-cancer
is 54 56 1787 1789 O
required 57 65 1790 1798 O
via 66 69 1799 1802 O
pathology 70 79 1803 1812 O
report 80 86 1813 1819 O

Histologically 0 14 1820 1834 O
or 15 17 1835 1837 O
cytologically 18 31 1838 1851 O
proven 32 38 1852 1858 O
metastatic 39 49 1859 1869 B-cancer
or 50 52 1870 1872 O
locally 53 60 1873 1880 O
advanced 61 69 1881 1889 O
solid 70 75 1890 1895 B-cancer
tumors 76 82 1896 1902 I-cancer
for 83 86 1903 1906 O
which 87 92 1907 1912 O
no 93 95 1913 1915 O
standard 96 104 1916 1924 B-treatment
therapy 105 112 1925 1932 I-treatment
exists 113 119 1933 1939 O
or 120 122 1940 1942 O
standard 123 131 1943 1951 O
therapy 132 139 1952 1959 O
has 140 143 1960 1963 O
failed 144 150 1964 1970 O

Known 0 5 1971 1976 O
history 6 13 1977 1984 O
of 14 16 1985 1987 O
testing 17 24 1988 1995 O
positive 25 33 1996 2004 O
for 34 37 2005 2008 O
human 38 43 2009 2014 B-chronic_disease
immunodeficiency 44 60 2015 2031 I-chronic_disease
virus 61 66 2032 2037 I-chronic_disease
( 67 68 2038 2039 I-chronic_disease
HIV 68 71 2039 2042 I-chronic_disease
) 71 72 2042 2043 I-chronic_disease
or 73 75 2044 2046 O
known 76 81 2047 2052 O
acquired 82 90 2053 2061 B-chronic_disease
immunodeficiency 91 107 2062 2078 I-chronic_disease
syndrome 108 116 2079 2087 I-chronic_disease
( 117 118 2088 2089 I-chronic_disease
AIDS 118 122 2089 2093 I-chronic_disease
) 122 123 2093 2094 I-chronic_disease

Known 0 5 2095 2100 O
severe 6 12 2101 2107 O
hypersensitivity 13 29 2108 2124 O
reactions 30 39 2125 2134 O
to 40 42 2135 2137 O
monoclonal 43 53 2138 2148 B-allergy_name
antibodies 54 64 2149 2159 I-allergy_name
( 65 66 2160 2161 O
NCI 66 69 2161 2164 B-clinical_variable
CTCAE 70 75 2165 2170 I-clinical_variable
grade 76 81 2171 2176 I-clinical_variable
≥3 82 84 2177 2179 O
) 84 85 2179 2180 O

Persisting 0 10 2181 2191 O
toxicity 11 19 2192 2200 O
related 20 27 2201 2208 O
to 28 30 2209 2211 O
prior 31 36 2212 2217 B-treatment
therapy 37 44 2218 2225 I-treatment
of 45 47 2226 2228 O
NCI 48 51 2229 2232 B-clinical_variable
CTCAE 52 57 2233 2238 I-clinical_variable
grade 58 63 2239 2244 I-clinical_variable
> 64 65 2245 2246 O
1 65 66 2246 2247 B-lower_bound
severity 67 75 2248 2256 O

Pregnancy 0 9 2257 2266 B-pregnancy

Prior 0 5 2267 2272 B-treatment
therapy 6 13 2273 2280 I-treatment
with 14 18 2281 2285 O
any 19 22 2286 2289 O
antibody 23 31 2290 2298 B-treatment
/ 31 32 2298 2299 I-treatment
drug 32 36 2299 2303 I-treatment
targeting 37 46 2304 2313 I-treatment
T 47 48 2314 2315 I-treatment
- 48 49 2315 2316 I-treatment
cell 49 53 2316 2320 I-treatment
co 54 56 2321 2323 I-treatment
- 56 57 2323 2324 I-treatment
regulatory 57 67 2324 2334 I-treatment
proteins 68 76 2335 2343 I-treatment
( 77 78 2344 2345 I-treatment
immune 78 84 2345 2351 I-treatment
checkpoints 85 96 2352 2363 I-treatment
) 96 97 2363 2364 I-treatment
such 98 102 2365 2369 O
as 103 105 2370 2372 O
anti 106 110 2373 2377 B-treatment
- 110 111 2377 2378 I-treatment
PD-1 111 115 2378 2382 I-treatment
, 115 116 2382 2383 O
anti 117 121 2384 2388 B-treatment
- 121 122 2388 2389 I-treatment
PD 122 124 2389 2391 I-treatment
- 124 125 2391 2392 I-treatment
L1 125 127 2392 2394 I-treatment
, 127 128 2394 2395 O
or 129 131 2396 2398 O
anti 132 136 2399 2403 B-treatment
- 136 137 2403 2404 I-treatment
cytotoxic 137 146 2404 2413 I-treatment
T 147 148 2414 2415 I-treatment
- 148 149 2415 2416 I-treatment
lymphocyte 149 159 2416 2426 I-treatment
antigen 160 167 2427 2434 I-treatment
4 168 169 2435 2436 I-treatment
( 170 171 2437 2438 I-treatment
CTLA-4 171 177 2438 2444 I-treatment
) 177 178 2444 2445 I-treatment
antibodies 179 189 2446 2456 I-treatment

Receipt 0 7 2457 2464 O
of 8 10 2465 2467 O
any 11 14 2468 2471 O
organ 15 20 2472 2477 B-treatment
transplantation 21 36 2478 2493 I-treatment
, 36 37 2493 2494 O
including 38 47 2495 2504 O
allogeneic 48 58 2505 2515 B-treatment
stem 59 63 2516 2520 I-treatment
- 63 64 2520 2521 I-treatment
cell 64 68 2521 2525 I-treatment
transplantation 69 84 2526 2541 I-treatment

Sensory 0 7 2542 2549 B-clinical_variable
neuropathy 8 18 2550 2560 I-clinical_variable
of 19 21 2561 2563 O
grade 22 27 2564 2569 O
≤2 28 30 2570 2572 O
is 31 33 2573 2575 O
acceptable 34 44 2576 2586 O

Small 0 5 2587 2592 B-treatment
molecule 6 14 2593 2601 I-treatment
or 15 17 2602 2604 I-treatment
antibody 18 26 2605 2613 I-treatment
targeted 27 35 2614 2622 I-treatment
therapy 36 43 2623 2630 I-treatment
is 44 46 2631 2633 O
permissible 47 58 2634 2645 O
< 59 60 2646 2647 O
14 60 62 2647 2649 B-upper_bound
days 63 67 2650 2654 I-upper_bound
from 68 72 2655 2659 O
start 73 78 2660 2665 O
of 79 81 2666 2668 O
trial 82 87 2669 2674 B-treatment
treatment 88 97 2675 2684 I-treatment

Steroids 0 8 2685 2693 B-treatment
with 9 13 2694 2698 O
no 14 16 2699 2701 O
or 17 19 2702 2704 O
minimal 20 27 2705 2712 O
systemic 28 36 2713 2721 O
effect 37 43 2722 2728 O
( 44 45 2729 2730 O
topical 45 52 2730 2737 O
, 52 53 2737 2738 O
inhalation 54 64 2739 2749 O
) 64 65 2749 2750 O

Subjects 0 8 2751 2759 O
must 9 13 2760 2764 O
have 14 18 2765 2769 O
had 19 22 2770 2773 O
one 23 26 2774 2777 O
prior 27 32 2778 2783 O
systemic 33 41 2784 2792 O
chemotherapeutic 42 58 2793 2809 O
regimen 59 66 2810 2817 O
for 67 70 2818 2821 O
management 71 81 2822 2832 O
of 82 84 2833 2835 O
persistent 85 95 2836 2846 O
, 95 96 2846 2847 O
recurrent 97 106 2848 2857 O
, 106 107 2857 2858 O
or 108 110 2859 2861 O
metastatic 111 121 2862 2872 B-cancer
carcinoma 122 131 2873 2882 I-cancer
of 132 134 2883 2885 I-cancer
the 135 138 2886 2889 I-cancer
cervix 139 145 2890 2896 I-cancer
( 146 147 2897 2898 O
e.g. 147 151 2898 2902 O
, 151 152 2902 2903 O
paclitaxel 153 163 2904 2914 B-treatment
/ 163 164 2914 2915 O
cisplatin 164 173 2915 2924 B-treatment
, 173 174 2924 2925 O
paclitaxel 175 185 2926 2936 O
/ 185 186 2936 2937 O
cisplatin 186 195 2937 2946 O
/ 195 196 2946 2947 O
bevacizumab 196 207 2947 2958 B-treatment
) 207 208 2958 2959 O

Subjects 0 8 2960 2968 O
must 9 13 2969 2973 O
have 14 18 2974 2978 O
persistent 19 29 2979 2989 O
, 29 30 2989 2990 O
recurrent 31 40 2991 3000 O
, 40 41 3000 3001 O
or 42 44 3002 3004 O
metastatic 45 55 3005 3015 B-cancer
squamous 56 64 3016 3024 I-cancer
cell 65 69 3025 3029 I-cancer
carcinoma 70 79 3030 3039 I-cancer
, 79 80 3039 3040 O
adenosquamous 81 94 3041 3054 B-cancer
carcinoma 95 104 3055 3064 I-cancer
or 105 107 3065 3067 O
adenocarcinoma 108 122 3068 3082 B-cancer
of 123 125 3083 3085 I-cancer
the 126 129 3086 3089 I-cancer
cervix 130 136 3090 3096 I-cancer
, 136 137 3096 3097 O
with 138 142 3098 3102 O
documented 143 153 3103 3113 O
disease 154 161 3114 3121 O
progression 162 173 3122 3133 O
( 174 175 3134 3135 O
disease 175 182 3135 3142 O
not 183 186 3143 3146 O
amenable 187 195 3147 3155 O
to 196 198 3156 3158 O
curative 199 207 3159 3167 O
therapy 208 215 3168 3175 B-treatment
) 215 216 3175 3176 O

Subjects 0 8 3177 3185 O
must 9 13 3186 3190 O
have 14 18 3191 3195 O
recurrent 19 28 3196 3205 O
, 28 29 3205 3206 O
unresectable 30 42 3207 3219 O
, 42 43 3219 3220 O
or 44 46 3221 3223 O
metastatic 47 57 3224 3234 B-cancer
cervical 58 66 3235 3243 I-cancer
cancer 67 73 3244 3250 I-cancer

Subjects 0 8 3251 3259 O
receiving 9 18 3260 3269 O
bisphosphonate 19 33 3270 3284 B-treatment
or 34 36 3285 3287 O
denosumab 37 46 3288 3297 B-treatment
are 47 50 3298 3301 O
eligible 51 59 3302 3310 O
provided 60 68 3311 3319 O
that 69 73 3320 3324 O
treatment 74 83 3325 3334 B-treatment
was 84 87 3335 3338 O
initiated 88 97 3339 3348 O
≥14 98 101 3349 3352 O
days 102 106 3353 3357 I-lower_bound
before 107 113 3358 3364 O
first 114 119 3365 3370 O
dose 120 124 3371 3375 O
of 125 127 3376 3378 O
AGEN2034 128 136 3379 3387 B-treatment

Subjects 0 8 3388 3396 O
receiving 9 18 3397 3406 O
immunosuppressive 19 36 3407 3424 B-treatment
agents 37 43 3425 3431 I-treatment
( 44 45 3432 3433 O
such 45 49 3433 3437 O
as 50 52 3438 3440 O
steroids 53 61 3441 3449 B-treatment
) 61 62 3449 3450 O
for 63 66 3451 3454 O
any 67 70 3455 3458 O
reason 71 77 3459 3465 O
should 78 84 3466 3472 O
be 85 87 3473 3475 O
tapered 88 95 3476 3483 O
off 96 99 3484 3487 O
these 100 105 3488 3493 O
drugs 106 111 3494 3499 O
14 112 114 3500 3502 B-upper_bound
days 115 119 3503 3507 I-upper_bound
before 120 126 3508 3514 O
initiation 127 137 3515 3525 O
of 138 140 3526 3528 O
study 141 146 3529 3534 O
treatment 147 156 3535 3544 O

Use 0 3 3545 3548 O
of 4 6 3549 3551 O
inhaled 7 14 3552 3559 B-treatment
or 15 17 3560 3562 I-treatment
topical 18 25 3563 3570 I-treatment
corticosteroid 26 40 3571 3585 I-treatment
is 41 43 3586 3588 O
permitted 44 53 3589 3598 O

WBC 0 3 3599 3602 B-clinical_variable
≥3 4 6 3603 3605 O
× 7 8 3606 3607 I-lower_bound
10 9 11 3608 3610 I-lower_bound
^ 11 12 3610 3611 I-lower_bound
9 12 13 3611 3612 I-lower_bound
/ 13 14 3612 3613 I-lower_bound
L 14 15 3613 3614 I-lower_bound

absolute 0 8 3615 3623 B-clinical_variable
neutrophil 9 19 3624 3634 I-clinical_variable
count 20 25 3635 3640 I-clinical_variable
( 26 27 3641 3642 I-clinical_variable
ANC 27 30 3642 3645 I-clinical_variable
) 30 31 3645 3646 I-clinical_variable
≥1.5 32 36 3647 3651 O
× 37 38 3652 3653 I-lower_bound
10 39 41 3654 3656 I-lower_bound
^ 41 42 3656 3657 I-lower_bound
9 42 43 3657 3658 I-lower_bound
/ 43 44 3658 3659 I-lower_bound
L 44 45 3659 3660 I-lower_bound

administration 0 14 3661 3675 O
of 15 17 3676 3678 O
inactivated 18 29 3679 3690 B-treatment
vaccines 30 38 3691 3699 I-treatment
( 39 40 3700 3701 O
e.g. 40 44 3701 3705 O
, 44 45 3705 3706 O
inactivated 46 57 3707 3718 O
influenza 58 67 3719 3728 B-treatment
vaccines 68 76 3729 3737 I-treatment
) 76 77 3737 3738 O

basal 0 5 3739 3744 B-cancer
or 6 8 3745 3747 I-cancer
squamous 9 17 3748 3756 I-cancer
cell 18 22 3757 3761 I-cancer
carcinoma 23 32 3762 3771 I-cancer
of 33 35 3772 3774 I-cancer
the 36 39 3775 3778 I-cancer
skin 40 44 3779 3783 I-cancer

cerebral 0 8 3784 3792 B-chronic_disease
vascular 9 17 3793 3801 I-chronic_disease
accident 18 26 3802 3810 I-chronic_disease
/ 26 27 3810 3811 I-chronic_disease
stroke 27 33 3811 3817 I-chronic_disease
( 34 35 3818 3819 O
< 35 36 3819 3820 O
6 36 37 3820 3821 B-upper_bound
months 38 44 3822 3828 I-upper_bound
before 45 51 3829 3835 O
enrollment 52 62 3836 3846 O
) 62 63 3846 3847 O

clear 0 5 3848 3853 B-cancer
cell 6 10 3854 3858 I-cancer
carcinoma 11 20 3859 3868 I-cancer

have 0 4 3869 3873 O
relapsed 5 13 3874 3882 O
after 14 19 3883 3888 O
a 20 21 3889 3890 O
platinum 22 30 3891 3899 O
- 30 31 3899 3900 O
containing 31 41 3900 3910 O
doublet 42 49 3911 3918 O
administered 50 62 3919 3931 O
for 63 66 3932 3935 O
treatment 67 76 3936 3945 O
of 77 79 3946 3948 O
advanced 80 88 3949 3957 O
( 89 90 3958 3959 O
recurrent 90 99 3959 3968 B-chronic_disease
, 99 100 3968 3969 I-chronic_disease
unresectable 101 113 3970 3982 I-chronic_disease
, 113 114 3982 3983 I-chronic_disease
or 115 117 3984 3986 I-chronic_disease
metastatic 118 128 3987 3997 I-chronic_disease
) 128 129 3997 3998 I-chronic_disease
disease 130 137 3999 4006 I-chronic_disease

immunodeficiencies 0 18 4007 4025 B-chronic_disease

major 0 5 4026 4031 O
surgery 6 13 4032 4039 B-treatment
within 14 20 4040 4046 O
28 21 23 4047 4049 B-upper_bound
days 24 28 4050 4054 I-upper_bound
before 29 35 4055 4061 O
start 36 41 4062 4067 O
of 42 44 4068 4070 O
trial 45 50 4071 4076 O
treatment 51 60 4077 4086 O

minimal 0 7 4087 4094 B-cancer
deviation 8 17 4095 4104 I-cancer
/ 17 18 4104 4105 I-cancer
adenoma 18 25 4105 4112 I-cancer
malignum 26 34 4113 4121 I-cancer

myocardial 0 10 4122 4132 B-chronic_disease
infarction 11 21 4133 4143 I-chronic_disease
( 22 23 4144 4145 O
< 23 24 4145 4146 O
6 24 25 4146 4147 B-upper_bound
months 26 32 4148 4154 I-upper_bound
before 33 39 4155 4161 O
enrollment 40 50 4162 4172 O
) 50 51 4172 4173 O

paclitaxel 0 10 4174 4184 B-clinical_variable
and 11 14 4185 4188 O
carboplatin 15 26 4189 4200 B-clinical_variable
for 27 30 4201 4204 O
≤4 31 33 4205 4207 O
cycles 34 40 4208 4214 I-upper_bound

palliative 0 10 4215 4225 B-treatment
bone 11 15 4226 4230 I-treatment
- 15 16 4230 4231 I-treatment
directed 16 24 4231 4239 I-treatment
radiotherapy 25 37 4240 4252 I-treatment

prior 0 5 4253 4258 B-treatment
diagnostic 6 16 4259 4269 I-treatment
biopsy 17 23 4270 4276 I-treatment

radiotherapy 0 12 4277 4289 B-treatment

subjects 0 8 4290 4298 O
with 9 13 4299 4303 O
castration 14 24 4304 4314 B-cancer
- 24 25 4314 4315 I-cancer
resistant 25 34 4315 4324 I-cancer
prostate 35 43 4325 4333 I-cancer
cancer 44 50 4334 4340 I-cancer
( 51 52 4341 4342 I-cancer
CRPC 52 56 4342 4346 I-cancer
) 56 57 4346 4347 I-cancer
, 57 58 4347 4348 O
who 59 62 4349 4352 O
may 63 66 4353 4356 O
remain 67 73 4357 4363 O
on 74 76 4364 4366 O
treatment 77 86 4367 4376 B-treatment
with 87 91 4377 4381 O
luteinizing 92 103 4382 4393 B-treatment
hormone 104 111 4394 4401 I-treatment
- 111 112 4401 4402 I-treatment
releasing 112 121 4402 4411 I-treatment
hormone 122 129 4412 4419 I-treatment
agonists 130 138 4420 4428 I-treatment
or 139 141 4429 4431 I-treatment
antagonists 142 153 4432 4443 I-treatment

subjects 0 8 4444 4452 O
with 9 13 4453 4457 O
diabetes 14 22 4458 4466 B-chronic_disease
type 23 27 4467 4471 I-chronic_disease
1 28 29 4472 4473 I-chronic_disease
, 29 30 4473 4474 O
vitiligo 31 39 4475 4483 B-chronic_disease
, 39 40 4483 4484 O
psoriasis 41 50 4485 4494 B-chronic_disease
, 50 51 4494 4495 O
hypo- 52 57 4496 4501 B-chronic_disease
, 57 58 4501 4502 I-chronic_disease
or 59 61 4503 4505 I-chronic_disease
hyperthyroid 62 74 4506 4518 I-chronic_disease
disease 75 82 4519 4526 I-chronic_disease
not 83 86 4527 4530 O
requiring 87 96 4531 4540 O
immunosuppressive 97 114 4541 4558 B-treatment
treatment 115 124 4559 4568 I-treatment

total 0 5 4569 4574 B-clinical_variable
bilirubin 6 15 4575 4584 I-clinical_variable
≤1.5 16 20 4585 4589 O
× 21 22 4590 4591 I-upper_bound
ULN 23 26 4592 4595 I-upper_bound
; 26 27 4595 4596 O
AST 28 31 4597 4600 B-clinical_variable
≤2.5 32 36 4601 4605 O
× 37 38 4606 4607 I-upper_bound
ULN 39 42 4608 4611 I-upper_bound

unstable 0 8 4612 4620 B-chronic_disease
angina 9 15 4621 4627 I-chronic_disease

use 0 3 4628 4631 O
of 4 6 4632 4634 O
any 7 10 4635 4638 O
investigational 11 26 4639 4654 B-treatment
drug 27 31 4655 4659 I-treatment
within 32 38 4660 4666 O
28 39 41 4667 4669 B-upper_bound
days 42 46 4670 4674 I-upper_bound
before 47 53 4675 4681 O
start 54 59 4682 4687 O
of 60 62 4688 4690 O
trial 63 68 4691 4696 O
treatment 69 78 4697 4706 O

use 0 3 4707 4710 O
of 4 6 4711 4713 O
hormonal 7 15 4714 4722 B-treatment
agents 16 22 4723 4729 I-treatment
within 23 29 4730 4736 O
7 30 31 4737 4738 B-upper_bound
days 32 36 4739 4743 I-upper_bound
before 37 43 4744 4750 O
start 44 49 4751 4756 O
of 50 52 4757 4759 O
trial 53 58 4760 4765 B-treatment
treatment 59 68 4766 4775 I-treatment

within 0 6 4776 4782 O
28 7 9 4783 4785 B-upper_bound
days 10 14 4786 4790 I-upper_bound
before 15 21 4791 4797 O
start 22 27 4798 4803 O
of 28 30 4804 4806 O
trial 31 36 4807 4812 O
treatment 37 46 4813 4822 O

